Phillips-Medisize, a maker of drug delivery, medical devices and diagnostic products, announced Monday it will close its facility in Medford, Wis., that employs 170 people.
Hudson-based Phillips-Medisize said it will shut down the Medford facility in phases through the end of 2023.
"Phillips-Medisize operates in changing markets that require us to continually evaluate global capacity and capabilities to ensure we remain competitive for the long term," said Sally Hoffman, a spokeswoman.
Companies in various industries have implemented layoffs in recent months amid concerns about the possibility of a recession and macroeconomic volatility.
In July, Phillips-Medisize laid off 99 employees from its St. Croix Meadows facility in Hudson, citing a major scaling back in production needs from one major customer.
A representative for e-cigarette maker Juul Labs confirmed this month that it was the customer scaling back orders with the company. Phillips-Medisize produces some e-cigarette components for Juul.
The Medford facility does not make components for Juul, and the plant's closure is unrelated. A Juul spokesman said Monday there have been no changes to its production needs.
Phillips-Medisize employs about 2,300 workers across Wisconsin at locations in Hudson, Eau Claire, New Richmond, Menomonie and Phillips, where the company started in the 1960s.
